-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Data Knights Acquisition (NASDAQ:DKDCA) Vs. Bioqual (OTCMKTS:BIOQ) Head-To-Head Comparison
Data Knights Acquisition (NASDAQ:DKDCA) Vs. Bioqual (OTCMKTS:BIOQ) Head-To-Head Comparison
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
Earnings and Valuation
This table compares Data Knights Acquisition and Bioqual's top-line revenue, earnings per share and valuation.
Get Data Knights Acquisition alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Data Knights Acquisition | N/A | N/A | $5.14 million | N/A | N/A |
Bioqual | $66.15 million | 0.95 | $5.26 million | $5.89 | 11.88 |
Bioqual has higher revenue and earnings than Data Knights Acquisition.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Data Knights Acquisition and Bioqual, as reported by MarketBeat.Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Data Knights Acquisition | 0 | 0 | 0 | 0 | N/A |
Bioqual | 0 | 0 | 0 | 0 | N/A |
Institutional and Insider Ownership
97.3% of Data Knights Acquisition shares are held by institutional investors. 39.2% of Bioqual shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Data Knights Acquisition has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Bioqual has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500.
Profitability
This table compares Data Knights Acquisition and Bioqual's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Data Knights Acquisition | N/A | N/A | N/A |
Bioqual | 7.92% | 14.90% | 8.53% |
Summary
Bioqual beats Data Knights Acquisition on 6 of the 8 factors compared between the two stocks.
About Data Knights Acquisition
(Get Rating)
Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.
About Bioqual
(Get Rating)
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Receive News & Ratings for Data Knights Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Data Knights Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
數據騎士收購(納斯達克:DKDCA-Get Rating)和Bioqual(OTCMKTS:BioQ-Get Rating)都是小盤醫療公司,但哪種投資更好?我們將根據這兩家公司的收益、機構所有權、股息、風險、估值、盈利能力和分析師的建議對其進行對比。
Earnings and Valuation
收益和估值
This table compares Data Knights Acquisition and Bioqual's top-line revenue, earnings per share and valuation.
這張表格比較了數據騎士的收購和Bioqual的營收、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Data Knights Acquisition | N/A | N/A | $5.14 million | N/A | N/A |
Bioqual | $66.15 million | 0.95 | $5.26 million | $5.89 | 11.88 |
總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
數據騎士收購 | 不適用 | 不適用 | 514萬美元 | 不適用 | 不適用 |
Bioqual | 6615萬美元 | 0.95 | 526萬美元 | $5.89 | 11.88 |
Bioqual has higher revenue and earnings than Data Knights Acquisition.
Bioqual的收入和收益比Data Knight收購的更高。
Analyst Recommendations
分析師建議
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Data Knights Acquisition | 0 | 0 | 0 | 0 | N/A |
Bioqual | 0 | 0 | 0 | 0 | N/A |
銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
數據騎士收購 | 0 | 0 | 0 | 0 | 不適用 |
Bioqual | 0 | 0 | 0 | 0 | 不適用 |
Institutional and Insider Ownership
機構和內部人持股
97.3% of Data Knights Acquisition shares are held by institutional investors. 39.2% of Bioqual shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
97.3%的數據騎士收購股份由機構投資者持有。Bioqual 39.2%的股份由內部人士持有。強大的機構持股表明,大型基金管理公司、對衝基金和捐贈基金相信,一家公司的長期表現將好於大盤。
Risk & Volatility
風險與波動性
Data Knights Acquisition has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Bioqual has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500.
數據騎士收購的貝塔係數為-0.01,這意味着其股價的波動性比標準普爾500指數低101%。相比之下,Bioqual的貝塔係數為-0.18,這意味着其股價的波動性比標準普爾500指數低118%。
Profitability
盈利能力
This table compares Data Knights Acquisition and Bioqual's net margins, return on equity and return on assets.
此表比較了Data Knight收購和Bioqual的淨利潤率、股本回報率和資產回報率。
Net Margins | Return on Equity | Return on Assets | |
Data Knights Acquisition | N/A | N/A | N/A |
Bioqual | 7.92% | 14.90% | 8.53% |
淨利潤率 | 股本回報率 | 資產回報率 | |
數據騎士收購 | 不適用 | 不適用 | 不適用 |
Bioqual | 7.92% | 14.90% | 8.53% |
Summary
摘要
Bioqual beats Data Knights Acquisition on 6 of the 8 factors compared between the two stocks.
在兩隻股票比較的8個因素中,Bioqual在6個因素上擊敗了數據騎士收購。
About Data Knights Acquisition
關於數據騎士的收購
(Get Rating)
(獲取評級)
Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.
數據騎士收購公司沒有重要的業務。它打算與數據中心和互聯網技術領域的一家或多家企業進行合併、資本股票交換、資產收購、股票購買、重組或類似的業務合併。該公司成立於2021年,總部設在英國切辛頓。
About Bioqual
關於Bioqual
(Get Rating)
(獲取評級)
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Bioqual公司為美國的商業和政府客户提供體內和體外臨牀前研究服務。該公司提供新冠肺炎、艾滋病、流感、呼吸道合胞病毒感染和黃病毒感染(包括寨卡病毒、登革熱、瘧疾、肝炎和癌症)等領域的研究服務。它的服務還包括樣品處理、病毒庫生成、傳染性病毒定量、病毒中和試驗、血凝抑制試驗、定量聚合酶鏈式反應、抗原和抗體ELISA檢測、流式細胞儀、淋巴細胞增殖和其他基於細胞的分析。此外,公司還提供動物研究模型相關服務。Bioqual,Inc.成立於1981年,總部設在馬裏蘭州羅克維爾。
Receive News & Ratings for Data Knights Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Data Knights Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收數據騎士收購的新聞和評級-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收對Data Knight收購和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧